Skip to main content
. 2020 Apr 15;2(2):otaa023. doi: 10.1093/crocol/otaa023

TABLE 1.

Attrition

Step Description Patients, n (%)
1 Total patients in the IBD Partners cohort (as of June 30, 2019) 16,441
2 Patients having completed the clinical trial questionnaire at any visit 16,079 (97.8%)
3 Patients reporting either CD or UC diagnosis 15,662 (97.4%)
4 Patients reporting residence in the United States 14,747 (94.2%)
 4a Patients ever having reported taken or currently taking a clinical trial medication 1119 (7.6%)
 4b Patients never having reported taken or currently taking a clinical trial medication 13,628 (92.4%)